Nachrichten zur Teva Pharmaceutical Industries Limited Aktie

Teva Pharmaceutical (TEVA) presents at Global High Yiled & Leveraged Finance Virtual Conference-slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

EU probes Teva over Copaxone competition

The European Commission is investigating whether Teva acted to delay generic competition to its MS drug Copaxone in Europe....…

Pharmakonzern soll Multiple-Sklerose-Medikament bewusst teuer gehalten haben

Das Medikament Copaxone ist ein Kassenschlager des israelischen Pharmakonzerns Teva. Um günstigere Konkurrenz zu verhindern, soll das Unternehmen zu krummen…

EU Opens Formal Probe Against Teva For Anticompetitive Conduct

PETAH TIKVA (dpa-AFX) - The European Commission has opened a formal antitrust investigation against Israeli pharmaceutical company Teva Pharmaceutical Industries…

Teva slides as EU starts antitrust probe into Copaxone sales

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ROUNDUP/Teures MS-Medikament: EU-Kommission leitet Kartellverfahren ein

BRÜSSEL (dpa-AFX) - Die EU-Kommission ermittelt wegen möglicher Wettbewerbsverzerrung bei einem Multiple-Sklerose-Medikament gegen den Pharmakonzern Teva…

Teures MS-Medikament: EU-Kommission leitet Kartellverfahren ein

BRÜSSEL (dpa-AFX) - Die EU-Kommission ermittelt wegen möglicher Wettbewerbsverzerrung bei einem Multiple-Sklerose-Medikament gegen den Pharmakonzern Teva…

Insiderhandel: Exec. VP Chief Legal Officer verkauft Aktien von Teva Pharmaceutical Industries im Wert von 399.224$

Stark, David Matthew - Vorstand - Tag der Transaktion: 2021-03-01...…

Generic-Drug Labeling Strategy Likely to Survive Teva Rehearing

Court Signals Generic Drugs Can Be Sold With Limited-Use Labels...…

Is Teva Pharmaceuticals a Safe Stock to Buy Now?

The largest generic drug manufacturer in the world can be bought for pennies on the dollar....…

TEVA Stock Declines Despite Q4 Earnings and Sales Beat

TEVA beats on fourth-quarter earnings and sales. It issues its financial guidance for 2021. Stock down....…

Teva CEO Sees Risks in Relying on China for Drug Ingredients

Kåre Schultz said that while his company doesn’t manufacture its active ingredients in China, he expects the pandemic to bring…

Teva Pharmaceutical Industries (TEVA) Q4 2020 Earnings Call Transcript

TEVA earnings call for the period ending December 31, 2020....…

TEVA PHARMACEUTICAL INDUSTRIES LTD: 10-K Report

FORM 10-K...…

Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel

Teva Pharmaceuticals CEO Kare Schultz joins "Squawk on the Street" to discuss the rollout of Covid-19 vaccines in Israel....…

Teva Is in Discussions to Help Make Covid-19 Vaccines, CEO Says

Teva Is in Discussions to Help Make Covid-19 Vaccines, CEO Says...…

TEVA Q4 Earnings & Sales Beat Estimates, Stock Rises

TEVA beats earnings and sales for fourth-quarter 2020. It issues its financial guidance for 2021. Stock up...…

Teva Pharmaceutical Industries Limited 2020 Q4 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Stock Climbs as Earnings Hint at Turnaround

Sales of two key drugs were up, and the company expects them to rise further....…

Tevas stock rallies 2% on earnings

Shares of Teva Pharmaceutical Industries Ltd. gained 2.7% in premarket trading on Wednesday after the drugmaker beat expectations for…

Teva beats expectations with strong Q4 results

The Israeli pharmaceutical companys guidance sees similar revenue levels in 2021....…

Teva Pharma Projects FY21 Earnings In Line With Estimates

PETAH TIKVA (dpa-AFX) - While reporting its financial results for the fourth quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA)…

Teva Pharmaceutical Industries Limited Q4 adjusted earnings Beat Estimates

PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Limited (TEVA) revealed earnings for its fourth quarter that advanced from last year.The…

Recap: Teva Pharmaceutical Q4 Earnings

  Shares of Teva Pharmaceutical Indus (NYSE:TEVA) moved higher by 3.7% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings…

TEVA PHARMACEUTICAL INDUSTRIES LTD: 8-K Report

TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K...…

Should Value Investors Buy Teva Pharmaceutical Industries Ltd. (TEVA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…

Teva Pharmaceutical Q4 2020 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

TEVA PHARMACEUTICAL INDUSTRIES LTD: 8-K Report

8-K...…

Teva and Anna Sui Partner on a Budding Capsule Collection

GOLETA, Calif. , Feb. 2, 2021 /PRNewswire/ -- Teva ® …

TEVA PHARMACEUTICAL INDUSTRIES LTD: 8-K Report

8-K...…

Teva launches generic etonogestrel and ethinyl estradiol vaginal ring in U.S.

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Kare Schultz: Teva set for single-digit growth in 2021

Although cuts, consolidation and streamlining will continue, the Teva CEO told the JP Morgan Healthcare Conference that the company will…

Why Bill Miller Likes Teva, Gannett, and Bitcoin

7 notable value investors take part in Ariel Investments roundtable....…

Teva, MedinCell announce positive results for registration trial of TV-46000/mdc-IRM for patients with Schizophrenia

Trial enrollment was open to patients 13-65 years of age. In the RISE study, patients treated with the investigational subcutaneous…

Teva: Interesting, Despite Uncertainty Prevailing

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jon Najarian Sees Unusual Option Activity In Target And Teva

On CNBCs "Fast Money Halftime Report," Jon Najarian gave some unusual option activity plays. read more...…

Simplivia Healthcare buys diagnostics co Novamed

FIMI controlled Simplivia, whioch develops devices for the safe administration of hazardous drugs, operates out of the former Teva factory…

TEVA Pharmaceutical: "Best Idea for 2021"

Rye (www.aktiencheck.de) - Rating-Update: Kevin Kedra, Analyst von Gabelli & Company, wählt die Aktie des Biotechkonzerns TEVA Pharmaceutical Industries Ltd. (ISIN:…

IBI sees 50% upside in Teva

IBI analyst Steven Tepper sees a leaner and more efficient Teva returning to growth in 2021....…

Verbraucher hamstern im Corona-Herbst kaum noch Arzneien

FRANKFURT (dpa-AFX) - Die im ersten Corona-Lockdown hochgeschossene Nachfrage nach rezeptfreien Arzneien und Erkältungsmitteln hat sich…

Teva readying to distribute Covid-19 vaccine in Israel

Yossi Ofek, CEO of Teva Israel-SLE, which has sole rights to distribute the vaccines, says a large part of Israels…

Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?

Is Teva Pharmaceutical (TEVA) a great pick from the value investors perspective right now? Read on to know more....…

EU fines Teva €60.5m for "pay for delay" pact

The agreement was with Cephalon, which Teva subsequently acquired, concerning sleep disorder treatment modanifil....…

Teva, Cephalon Fined $72 Million by EU for Pay-for-Delay Pact

Teva, Cephalon Fined $72 Million by EU for Pay-for-Delay Pact...…

Vestager: Millionenstrafe für Pharmafirmen wegen illegaler Absprache

BRÜSSEL (dpa-AFX) - Die Pharmafirmen Teva und Cephalon sollen 60,5 Millionen Euro Strafe zahlen, weil…

TEVA SHAREHOLDER NOTICE

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss…

Teva Shareholder Alert

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss…

Teva Deadline Alert

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss…

Teva Lead Plaintiff Deadline Alert

Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss…

EU opens Teva antitrust probe

According to a report by Reuters, the investigation relates to Tevas multiple sclerosis treatment Copaxone....…